最高の Radcliffe Cardiology ポッドキャスト (2024)

1
View from the Thoraxcenter: EuroPCR 24 Late-breaking Science Preview 26:04

8d ago26:04

26:04

What's hot at EuroPCR 2024?Join interventional experts, Prof Nicolas Van Mieghem and Dr Joost Daemen from Erasmus MC's Thoraxcenter for an insightful preview of the late-breaking science data to look out for at the 2024 EuroPCR meeting.What is the potential impact of the new data on practice? What details should we look out for? What is the context…

1
HCM Practice Essentials: Setting-up an HCM Clinic 19:27

14d ago19:27

19:27

In the first episode, Prof Juan Pablo Kaski and Prof Ruxandra Jurcut discuss the essentials of establishing an HCM Clinic, covering its objectives, logistical aspects, systemic challenges, and operational strategies, including referral practices and collaboration with specialist centres.The Radcliffe Cardiology Podcast による

1
View from the Thoraxcenter: ACC.24 Late-breaking Science Wrap Up 43:48

1M ago43:48

43:48

Unpack ACC.24's Top Trials with View from the Thoraxcenter!Join Prof Nicolas Van Mieghem and Dr Joost Daemen from Erasmus MC, Rotterdam for a deep dive into the late-breaking data presented at ACC.24.In this thought-provoking ACC 2024 wrap-up, delve into the nuances of the most impactful trials, gaining insights into their implications for current …

1
Very-High Power Short Duration Vs Conventional Ablation for PVI in AF 29:53

5M ago29:53

29:53

In this episode of the Radcliffe Podcast, we are joined by Dr Raymond Pranata, Dr Mohammad Iqbal and Dr Giky Karwiky (Hasan Sadikin General Hospital, Bandung, Indonesia) as they discuss their recently published systematic review and meta-analysis of very-high-power short-duration ablation as compared to conventional ablation for the treatment of pu…

1
View from the Thoraxcenter: AHA 23 Late-breaking Science Wrap Up 23:14

6M ago23:14

23:14

What's hot at #AHA23?Join Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcentre, Erasmus MC, Rotterdam, NL) as they review the latest late-breaking science data from AHA Scientific Sessions 2023. They interpret the evidence from five key trials, providing context, asking thought-provoking questions to translate the data into key take-home mess…

1
View from the Thoraxcenter: TCT 23 Late-breaking Science Wrap Up 30:37

7M ago30:37

30:37

What are the top late-breaking trials from #TCT2023?TCT 2023 — Join interventional cardiologists, Prof Nicolas Van Mieghem and Dr Joost Daemen from the Thoraxcenter as they unpack the most impactful late-breaking clinical trials and science data from this year's Transcatheter Cardiovascular Therapeutics Conference.Dive into this practical and engag…

1
View from the Thoraxcenter: ESC 23 Late-breaking Science Wrap Up 47:56

8M ago47:56

47:56

What are the take-home messages from ESC 2O23?Join us as we delve into the pivotal results that ignited debates and discussions at ESC Congress 2023. Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcentre, Erasmus MC, Rotterdam, NL) return with their "View from the Thoraxcenter" review, where they analyse the hot line and late-breaking trials p…

1
View from the Thoraxcenter: ESC 23 Late-breaking Science Preview 28:32

9M ago28:32

28:32

What is hot at ESC 2023?In this episode of View of the Thoraxcenter, Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcenter, Erasmus MC, NL) preview the hot line and late-breaking data presented at ESC Congress 2023. With their dynamic analysis, they place these highly anticipated trials within a context, highlighting the real-world implication…

1
Left Main Percutaneous Coronary Revascularization 14:43

10M ago14:43

14:43

In this episode of the Radcliffe Podcast, we are joined by Dr Mirvat Alasnag (King Fahd Armed Forces Hospital, SA), Dr Khalid AlJohani (King Saud University, SA), and Dr Abdulrahman AlMoghairi (Prince Sultan Cardiac Center, SA) as they discuss methods and approaches to left main percutaneous coronary revascularization.In this podcast, Dr Alasnag, D…

1
Masterclass on Leadership: Forks in the Road with Dr Clyde W Yancy 30:06

11M ago30:06

30:06

Join Masterclass host, Dr. Harriette Van Spall (McMaster University, CA), in an in-depth interview with Dr. Clyde W. Yancy (Northwestern University, US).Dr. Yancy, an internationally respected leader and mentor in cardiology, holds positions as the Vice Dean of Diversity and Inclusion, Magerstadt Professor of Medicine, and Chief of the Division of …

1
Artificial Intelligence in Atrial Fibrillation 23:32

12M ago23:32

23:32

In this episode from the Radcliffe Podcast, Dr Francisco Lopez-Jimenez (Mayo Clinic, US) and Dr David Harmon (Mayo Clinic, US) join us to discuss the future of AI in Atrial Fibrillation treatment, based on Dr Harmon's recently published article in AER Journal; 'Artificial intelligence for the detection and treatment of atrial fibrillation'.Dr Lopez…

1
European Examination in Core Cardiology: APSC Exit Examination 15:54

1y ago15:54

15:54

In this episode of the Radcliffe Cardiology Podcast, we are joined by Dr Jack Tan (National Heart Centre, SG) and Dr Chris Plummer (The Newcastle upon Tyne Hospitals NHS Foundation Trust, UK), who provide an overview of a recent JAPSC Journal article based on the European Examination in Core Cardiology. The test aims to provide a broad and balanced…

1
View from the Thoraxcenter: What's Hot at ACC.23? 22:04

1y ago22:04

22:04

In this episode of "View from the Thoraxcenter," Prof Nicolas Van Mieghem and Dr Joost Daemen preview the most anticipated late-breaking and featured science trials of ACC.23 and discuss their potential impact on patient care and research. The trials covered include structural interventions such as TRILUMINATE Pivotal, UK Mini Mitral, COAPT, and Ev…

1
Ep 1: Breaking the Cycle of Heart Failure With Preserved Ejection Fraction and Atrial Fibrillation 20:52

1+ y ago20:52

20:52

In this episode of the Radcliffe Cardiology Podcast, Dr Otilia Tica (University of Birmingham, UK) is joined by Patient Representative, Mary Stanbury to outline ways in which cardiologists can break the cycle of heart failure with preserved ejection fraction (HFpEF) and atrial fibrillation (AF). This discussion is centered around a recently publish…

1
Ep 11: Sex Differences in Hypertension: Diagnosis, awareness, and control 19:39

1+ y ago19:39

19:39

In the third part of ECR Podcast's series on sex-differences in hypertension, Dr Isabella Sudano (University Hospital and University of Zurich, Zurich, CH) and Dr Eva Gerdts (Haukeland University Hospital, Bergen, NO) are joined by Prof Renata Cifkova (Institute of Experimental Medicine, Prague, CZ) to discuss the diagnosis of hypertension in women…

1
Ep 10: Sex Differences in Hypertension: Cardiovascular complications 22:49

1+ y ago22:49

22:49

In the second part of ECR Podcast's series on sex-differences in hypertension, Dr Isabella Sudano (University Hospital and University of Zurich, Zurich, CH) and Dr Eva Gerdts (Haukeland University Hospital, Bergen, NO) are joined by Dr Angela Maas (Radboud University Medical Center, Nijmegen, NL) to talk about the cardiovascular complications that …

1
Ep 9: Sex Differences in Hypertension: Pharmacological Treatment 25:40

1+ y ago25:40

25:40

In the first of a three-part ECR Podcast series on hypertension in women, Dr Isabella Sudano (University Hospital and University of Zurich, Zurich, CH) and Dr Eva Gerdts (Haukeland University Hospital, Bergen, NO) are joined by Prof Juan Tamargo (University Complutense, Madrid, ES) to discuss pharmalogical treatment options and considerations.Discu…

1
Ep 8: The Role of CT Coronary Angiography in Chronic Total Occlusion Intervention 23:47

1+ y ago23:47

23:47

What considerations must be made when screening chronic total occlusion patients undergoing PCI, and how can CT be used in daily practice?In this month's episode of ECR Podcast, Dr Vinoda Sharma, (Sandwell and West Birmingham Hospitals NHS Trust, Birmingham, UK) and Dr Abdul Mozid, (Leeds Teaching Hospitals NHS Trust, Leeds, UK) discuss the ways in…

1
Ep 7: Socioeconomic Factors Impacting Coronary and Structural Intervention 26:25

1+ y ago26:25

26:25

What are the social factors that impact access to coronary and structural intervention in the current landscape of cardiology?In this month's episode of ECR Podcast, guest editor of ECR's special focus on gender disparities in interventional and structural heart procedures, Dr Natalia Berry (Mid Atlantic Permanente Medical Group, Washington DC, USA…

1
Ep 6: Inflammatory Biomarkers and Cardiovascular Risk 28:46

2y ago28:46

28:46

What are the clinical challenges in the use of biomarkers to estimate the risk of a cardiovascular event?Join Dr Bruna Gigante (Karolinska Institute, Solna, SE) in a discussion of potential biomarkers which may impact a patient’s cardiovascular risk profile. In this month’s featured author episode of the ECR Podcast, Dr Gigante discusses novel biom…

1
Targeting Inflammation in Atherosclerosis: Current Guidelines and Clinical Data 7:25

2y ago7:25

7:25

Join Prof Juan Carlos Kaski (St George’s University of London, UK) and Dr Aernoud Fiolet (University Medical Center Utrecht, Netherlands) as they explore topics such as how guidelines currently view anti-inflammatory approaches and main molecules under investigation.Supported by an unrestricted educational grant from NOVO NORDISK A/S.…

1
Targeting Inflammation in Atherosclerosis: Therapeutic Targets and Mode of Action 6:42

2y ago6:42

6:42

Prof Juan Carlos Kaski (St George’s University of London, UK) alongside Dr Peter Libby (Brigham and Women’s Hospital, Boston, US) provide us with a short and concise discussion regarding Therapeutic Targets and Mode of Action.Supported by an unrestricted educational grant from NOVO NORDISK A/S.The Radcliffe Cardiology Podcast による

1
Targeting Inflammation in Atherosclerosis: Inflammation and Atherosclerosis 8:39

2y ago8:39

8:39

Inflammation and Atherosclerosis – What is the Link with CKD? Join Prof Juan Carlos Kaski (St George’s University of London, UK) and Prof Lina Badimon (Hospital of Santa Creu and San Pau, Barcelona, Spain) as they discuss that very question.Supported by an unrestricted educational grant from NOVO NORDISK A/S.…

1
Targeting Inflammation in Atherosclerosis: Inflammatory Signalling in Atherosclerosis and CKD 8:36

2y ago8:36

8:36

Inflammatory Signalling in Atherosclerosis and CKD is the topic of interest in this short peer to peer discussion involving Prof Juan Carlos Kaski (St George’s University of London, UK) and Prof Paul Ridker (Brigham and Women’s Hospital, Boston, US).Supported by an unrestricted educational grant from NOVO NORDISK A/S.…

1
Targeting Inflammation in Atherosclerosis: Unmet Clinical Needs in Atherosclerosis & CKD 9:49

2y ago9:49

9:49

Prof Juan Carlos Kaski (St George’s University of London, UK) is joined by Prof Paul Ridker (Brigham and Women’s Hospital, Boston, US) to discuss Unmet Clinical Needs in Atherosclerosis and Chronic Kidney Disease where they cover topics such as elevated hsCRP and chronic kidney disease.Supported by an unrestricted educational grant from NOVO NORDIS…

1
Targeting Inflammation in Atherosclerosis: COLCOT Trial | Prof Jean-Claude Tardif 5:13

2y ago5:13

5:13

Prof Jean-Claude Tardif (Montreal Heart Institute, Canada) gives us a comprehensive overview of the COLCOT trial.Supported by an unrestricted educational grant from NOVO NORDISK A/S.The Radcliffe Cardiology Podcast による

1
Targeting Inflammation in Atherosclerosis: LoDoCo2 Trial | Dr Aernoud Fiolet 5:03

2y ago5:03

5:03

In this LoDoCo2 presentation, Dr Aernoud Fiolet (University Medical Center Utrecht, Netherlands) covers the trial design and main results.Supported by an unrestricted educational grant from NOVO NORDISK A/S.The Radcliffe Cardiology Podcast による

1
Targeting Inflammation in Atherosclerosis: CANTOS Trial | Dr Paul Ridker 6:19

2y ago6:19

6:19

Prof Paul Ridker (Brigham and Women’s Hospital, Boston, US) provides us with an overview of the CANTOS main trial results and updated results from the ACC 2022.Supported by an unrestricted educational grant from NOVO NORDISK A/S.The Radcliffe Cardiology Podcast による

1
Targeting Inflammation in Atherosclerosis: RESCUE Trial | Dr Peter Libby 4:22

2y ago4:22

4:22

Join Dr Peter Libby (Brigham and Women’s Hospital, Boston, US) as he talks us through the RESCUE trial design and results in this short podcast.Supported by an unrestricted educational grant from NOVO NORDISK A/S.The Radcliffe Cardiology Podcast による

1
Ep 5: Invasive Diagnosis of Coronary Functional Disorders Causing Angina Pectoris 29:28

2y ago29:28

29:28

Did you know that coronary vasomotion disorders are a frequent cause of angina in patients with non-obstructed coronary arteries?In this month's episode of the ECR podcast, Dr Andreas Seitz and Dr Peter Ong (Robert-Bosch Hospital, Stuttgart, DE) return to discuss their recent article on the diagnosis of coronary disorders which cause angina (https:…

1
Ep 4: The EXCEL Trial: The Interventionalists’ Perspective 12:40

2+ y ago12:40

12:40

Did you know that left main stem disease is identified in 5% of diagnostic angiography cases?The EXCEL trial was a randomised clinical trial published in 2019 which studied left main stem disease of low or intermediate complexity. The trial came under controversy due to its definition of MI, leading to a loss in patient and public trust, and a dete…

1
Ep 3: Atrial Fibrillation in Congenital Heart Disease 16:52

2+ y ago16:52

16:52

Did you know that atrial arrhythmias are the most common complication in adults with congenital heart disease?Dr Irene Martin de Miguel (Adult Congenital Heart Disease Fellow at Mayo Clinic Rochester, US) joins us in this featured author episode to outline her recent review article, Atrial Fibrillation in Congenital Heart Disease. In this podcast, …

1
Ep 2: Prognostication of patients with coronary stenoses: pre-and post-PCI 20:38

2+ y ago20:38

20:38

Is there enough evidence to support the prognostic value of coronary physiology measurements in pre-and post-PCI settings? Is post-PCI FFR ready for clinical practice?Today's episode features co-hosts Dr Peter Ong and Dr Andreas Seitz (Robert-Bosch Hospital, Stuttgart, DE) who together summarise the main results from the TARGET FFR and DEFINE-FLOW …

1
Ep 1: Women and Heart Disease 44:44

2+ y ago44:44

44:44

Did you know that CV disease is the leading cause of death in women and that women are more likely to die of heart disease compared to men?Dr Erin Michos (Johns Hopkins Uni, US) and Dr Martha Gulati (Uni of Arizona, US) join us on the inaugural episode of the ECR podcast series to discuss issues surrounding women in heart disease. Together they exp…

聞く価値のあるポッドキャスト

ポッドキャスト Radcliffe Cardiology

聞く価値のあるポッドキャスト

1
The Radcliffe Cardiology Podcast

The Radcliffe Cardiology Podcast

1
View from the Thoraxcenter: EuroPCR 24 Late-breaking Science Preview 26:04

1
HCM Practice Essentials: Setting-up an HCM Clinic 19:27

1
View from the Thoraxcenter: ACC.24 Late-breaking Science Wrap Up 43:48

1
Very-High Power Short Duration Vs Conventional Ablation for PVI in AF 29:53

1
View from the Thoraxcenter: AHA 23 Late-breaking Science Wrap Up 23:14

1
View from the Thoraxcenter: TCT 23 Late-breaking Science Wrap Up 30:37

1
View from the Thoraxcenter: ESC 23 Late-breaking Science Wrap Up 47:56

1
View from the Thoraxcenter: ESC 23 Late-breaking Science Preview 28:32

1
Left Main Percutaneous Coronary Revascularization 14:43

1
Masterclass on Leadership: Forks in the Road with Dr Clyde W Yancy 30:06

1
Artificial Intelligence in Atrial Fibrillation 23:32

1
European Examination in Core Cardiology: APSC Exit Examination 15:54

1
View from the Thoraxcenter: What's Hot at ACC.23? 22:04

1
Ep 1: Breaking the Cycle of Heart Failure With Preserved Ejection Fraction and Atrial Fibrillation 20:52

1
Ep 11: Sex Differences in Hypertension: Diagnosis, awareness, and control 19:39

1
Ep 10: Sex Differences in Hypertension: Cardiovascular complications 22:49

1
Ep 9: Sex Differences in Hypertension: Pharmacological Treatment 25:40

1
Ep 8: The Role of CT Coronary Angiography in Chronic Total Occlusion Intervention 23:47

1
Ep 7: Socioeconomic Factors Impacting Coronary and Structural Intervention 26:25

1
Ep 6: Inflammatory Biomarkers and Cardiovascular Risk 28:46

1
Targeting Inflammation in Atherosclerosis: Current Guidelines and Clinical Data 7:25

1
Targeting Inflammation in Atherosclerosis: Therapeutic Targets and Mode of Action 6:42

1
Targeting Inflammation in Atherosclerosis: Inflammation and Atherosclerosis 8:39

1
Targeting Inflammation in Atherosclerosis: Inflammatory Signalling in Atherosclerosis and CKD 8:36

1
Targeting Inflammation in Atherosclerosis: Unmet Clinical Needs in Atherosclerosis & CKD 9:49

1
Targeting Inflammation in Atherosclerosis: COLCOT Trial | Prof Jean-Claude Tardif 5:13

1
Targeting Inflammation in Atherosclerosis: LoDoCo2 Trial | Dr Aernoud Fiolet 5:03

1
Targeting Inflammation in Atherosclerosis: CANTOS Trial | Dr Paul Ridker 6:19

1
Targeting Inflammation in Atherosclerosis: RESCUE Trial | Dr Peter Libby 4:22

1
Ep 5: Invasive Diagnosis of Coronary Functional Disorders Causing Angina Pectoris 29:28

1
Ep 4: The EXCEL Trial: The Interventionalists’ Perspective 12:40

1
Ep 3: Atrial Fibrillation in Congenital Heart Disease 16:52

1
Ep 2: Prognostication of patients with coronary stenoses: pre-and post-PCI 20:38

1
Ep 1: Women and Heart Disease 44:44

クイックリファレンスガイド